Conservative Management of Placenta Accreta Spectrum

Clin Obstet Gynecol. 2018 Dec;61(4):783-794. doi: 10.1097/GRF.0000000000000395.

Abstract

The purpose of this review was to assist obstetricians and gynecologists in considering the most appropriate conservative treatment option to manage women with placenta accreta spectrum according to their individual need and local expertise of the heath care team. The issue is challenging, as the quality of evidence with regard to efficacy is poor, and is mainly based on retrospective studies with limited sample size.

Publication types

  • Review

MeSH terms

  • Cesarean Section / methods*
  • Conservative Treatment / methods*
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Humans
  • Hysterectomy
  • Hysteroscopy
  • Ligation
  • Methotrexate / therapeutic use
  • Organ Sparing Treatments
  • Placenta Accreta / surgery*
  • Placenta, Retained / prevention & control*
  • Placenta, Retained / therapy
  • Pregnancy
  • Uterine Artery / surgery
  • Uterine Artery Embolization

Substances

  • Enzyme Inhibitors
  • Methotrexate